Publications
Dernières publications
Oncolytic Viruses as a Platform for the Treatment of Malignant Brain Tumors. Sostoa J, Dutoit V, Migliorini D. Int J Mol Sci. 2020 Oct 9;21(20):7449. doi: 10.3390/ijms21207449. PMID: 33050329
Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies. Parker KR, Migliorini D, Perkey E, Yost KE, Bhaduri A, Bagga P, Haris M, Wilson NE, Liu F, Gabunia K, Scholler J, Montine TJ, Bhoj VG, Reddy R, Mohan S, Maillard I, Kriegstein AR, June CH, Chang HY, Posey AD Jr, Satpathy AT. Cell. 2020 Oct 1;183(1):126-142.e17. doi: 10.1016/j.cell.2020.08.022. Epub 2020 Sep 21. PMID: 32961131
An Experimentally Defined Hypoxia Gene Signature in Glioblastoma and Its Modulation by Metformin. Calvo Tardón M, Marinari E, Migliorini D, Bes V, Tankov S, Charrier E, McKee TA, Dutoit V, Dietrich PY, Cosset E, Walker PR. Biology (Basel). 2020 Sep 2;9(9):264. doi: 10.3390/biology9090264. PMID: 32887267
Impact of Radiochemotherapy on Immune Cell Subtypes in High-Grade Glioma Patients. Dutoit V, Philippin G, Widmer V, Marinari E, Vuilleumier A, Migliorini D, Schaller K, Dietrich PY. Front Oncol. 2020 Feb 14;10:89. doi: 10.3389/fonc.2020.00089. eCollection 2020. PMID: 32117743